cardiovascular cancer services
Biological Drug Development
in the diagnosis, treatment or prevention of diseases such as cancer, cardiovascular diseases, neurological diseases, autoimmune diseases and metabolic ...
By Creative Biolabs based in Aberdeen, HONG KONG.
Epigenetic Age Analysis Service
Aging is the largest risk factor for many chronic diseases including cancer, cardiovascular disease, arthritis, osteoporosis, and type 2 diabetes. Therefore, quantifying the biological age is a fundamental step of understanding diseases and designing anti-aging intervention. Dr. Steve Horvath's epigenetic ...
By Zymo Research Corporation based in Irvine, CALIFORNIA (USA).
Cardiotoxicity is a growing issue in Oncology: cardio-oncology is an emerging discipline focused predominantly on the detection and management of cancer treatment-induced cardiac dysfunction (cardiotoxicity). Around 20% of all cancer survivors will develop cardiovascular co-morbidities, with 1 in 10 cancer ...
By Genome Biologics based in Frankfurt am Main, GERMANY.
Public Health Assessment Services
Harvard School of Public Health in cooperation with Kadhema Scientific Consultancy and Services contracted by Public Authority for Assessment of Compensation for Damages resulting from the Iraqi Aggression (PAAC) carried out the health studies of the Environmental and Assessment (E&A) programme funded by the United Nations Compensation ...
By Kadhema Scientific Consultancy and Services (KSCS) based in Safat, KUWAIT. from Public Health Assessment Division (PHAD) Service line
Membrane Protein Identification Services
Membrane proteins such as receptors and ion channels are key regulators of cellular function. Membrane proteins account for up to two thirds of known drugable target, highlighting their critical pharmaceutical ...
By Creative Proteomics based in New York, NEW YORK (USA). from Proteomics Service - Protein Identification Service line
Antibody Design and Production Services
In recent years, the proportion of biological drugs in the global pharmaceutical market has been close to 20%. The focus within the global pharmaceutical market has been gradually shifting from small molecule chemical drugs to biomacromolecules (biological drugs). It also appears that the trend is gradually expanding. Biological drugs are a broad class of pharmaceuticals generated by using ...
By Synbio Technologies LLC based in NEW JERSEY (USA). from Antibody Discovery Services Service line
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you